Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for MAFB
Z-value: 1.72
Motif logo
Transcription factors associated with MAFB
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MAFB
|
ENSG00000204103.2 | MAF bZIP transcription factor B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MAFB | hg19_v2_chr20_-_39317868_39317884 | -0.79 | 1.6e-07 | Click! |
Activity profile of MAFB motif
Sorted Z-values of MAFB motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_+_53491220 | 5.40 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr17_+_7942424 | 5.39 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr12_-_76425368 | 5.07 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
| chr17_+_7942335 | 4.49 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr4_-_57547454 | 4.42 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
| chr4_-_57547870 | 4.39 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
| chr10_+_120967072 | 4.34 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
| chr2_+_191745560 | 4.20 |
ENST00000338435.4
|
GLS
|
glutaminase |
| chr2_+_238536207 | 3.90 |
ENST00000308482.9
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr16_-_85784557 | 3.82 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr1_+_20915409 | 3.68 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
| chr22_-_37640456 | 3.65 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr3_-_50340996 | 3.63 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr2_+_191745535 | 3.56 |
ENST00000320717.3
|
GLS
|
glutaminase |
| chr19_+_16187085 | 3.51 |
ENST00000300933.4
|
TPM4
|
tropomyosin 4 |
| chr7_-_128045984 | 3.47 |
ENST00000470772.1
ENST00000480861.1 ENST00000496200.1 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
| chr4_-_57522470 | 3.43 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr2_-_113594279 | 3.43 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr20_+_361261 | 3.34 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
| chr8_+_7752151 | 3.30 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
| chr11_-_64646086 | 3.29 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
| chr16_-_79633799 | 3.29 |
ENST00000569649.1
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
| chr19_-_49015050 | 3.25 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr1_+_203651937 | 3.20 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr1_-_111991850 | 3.04 |
ENST00000411751.2
|
WDR77
|
WD repeat domain 77 |
| chr1_-_50489547 | 2.94 |
ENST00000371836.1
ENST00000371839.1 ENST00000371838.1 |
AGBL4
|
ATP/GTP binding protein-like 4 |
| chr11_+_13690249 | 2.90 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
| chr20_-_23030296 | 2.86 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
| chr2_-_235405168 | 2.82 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr4_-_57522673 | 2.66 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr19_+_54371114 | 2.64 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr16_-_84538218 | 2.59 |
ENST00000562447.1
ENST00000565765.1 ENST00000535580.1 ENST00000343629.6 |
TLDC1
|
TBC/LysM-associated domain containing 1 |
| chr1_+_155583012 | 2.59 |
ENST00000462250.2
|
MSTO1
|
misato 1, mitochondrial distribution and morphology regulator |
| chr22_+_30792846 | 2.57 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr14_+_54863739 | 2.55 |
ENST00000541304.1
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
| chr4_-_57522598 | 2.54 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr3_-_111314230 | 2.53 |
ENST00000317012.4
|
ZBED2
|
zinc finger, BED-type containing 2 |
| chr1_+_45212074 | 2.53 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
| chr16_-_84651673 | 2.50 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr19_-_15343191 | 2.50 |
ENST00000221730.3
|
EPHX3
|
epoxide hydrolase 3 |
| chr2_+_113735575 | 2.45 |
ENST00000376489.2
ENST00000259205.4 |
IL36G
|
interleukin 36, gamma |
| chr16_-_84651647 | 2.44 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr20_+_34203794 | 2.43 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
| chr22_+_19466980 | 2.41 |
ENST00000407835.1
ENST00000438587.1 |
CDC45
|
cell division cycle 45 |
| chr16_-_88729473 | 2.41 |
ENST00000301012.3
ENST00000569177.1 |
MVD
|
mevalonate (diphospho) decarboxylase |
| chr14_+_54863682 | 2.39 |
ENST00000543789.2
ENST00000442975.2 ENST00000458126.2 ENST00000556102.2 |
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
| chr14_+_75745477 | 2.39 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr4_+_8201091 | 2.38 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
| chr14_+_85996471 | 2.38 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr1_+_45212051 | 2.35 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
| chr7_-_76256557 | 2.35 |
ENST00000275569.4
ENST00000310842.4 |
POMZP3
|
POM121 and ZP3 fusion |
| chr17_+_40610862 | 2.34 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
| chr19_+_35645618 | 2.33 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr5_-_139726181 | 2.31 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr2_-_31361543 | 2.30 |
ENST00000349752.5
|
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr6_+_151561506 | 2.30 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr5_-_59995921 | 2.29 |
ENST00000453022.2
ENST00000545085.1 ENST00000265036.5 |
DEPDC1B
|
DEP domain containing 1B |
| chr21_-_47648665 | 2.27 |
ENST00000450351.1
ENST00000522411.1 ENST00000356396.4 ENST00000397728.3 ENST00000457828.2 |
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
| chr12_+_50366620 | 2.25 |
ENST00000315520.5
|
AQP6
|
aquaporin 6, kidney specific |
| chr14_+_54863667 | 2.22 |
ENST00000335183.6
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
| chr22_+_19467261 | 2.21 |
ENST00000455750.1
ENST00000437685.2 ENST00000263201.1 ENST00000404724.3 |
CDC45
|
cell division cycle 45 |
| chr19_+_16186903 | 2.21 |
ENST00000588507.1
|
TPM4
|
tropomyosin 4 |
| chr22_+_31489344 | 2.20 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr19_-_51014345 | 2.20 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr6_+_34204642 | 2.20 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr1_-_109935819 | 2.19 |
ENST00000538502.1
|
SORT1
|
sortilin 1 |
| chr15_-_40212363 | 2.19 |
ENST00000299092.3
|
GPR176
|
G protein-coupled receptor 176 |
| chr4_+_75310851 | 2.17 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr6_-_42946947 | 2.16 |
ENST00000304611.8
|
PEX6
|
peroxisomal biogenesis factor 6 |
| chr2_+_233925064 | 2.15 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr20_+_33759854 | 2.14 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr7_+_77167343 | 2.11 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr4_+_75311019 | 2.09 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr21_-_44846999 | 2.07 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr8_-_6735451 | 2.06 |
ENST00000297439.3
|
DEFB1
|
defensin, beta 1 |
| chr22_+_30792980 | 2.04 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr12_-_48152611 | 2.03 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr20_-_56284816 | 2.02 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr12_-_124018252 | 2.01 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
| chr1_-_67519782 | 2.01 |
ENST00000235345.5
|
SLC35D1
|
solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1 |
| chr4_+_156680518 | 1.99 |
ENST00000513437.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr19_-_43269809 | 1.97 |
ENST00000406636.3
ENST00000404209.4 ENST00000306511.4 |
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
| chr10_-_106098162 | 1.97 |
ENST00000337478.1
|
ITPRIP
|
inositol 1,4,5-trisphosphate receptor interacting protein |
| chr1_-_111991908 | 1.97 |
ENST00000235090.5
|
WDR77
|
WD repeat domain 77 |
| chr17_-_39274606 | 1.96 |
ENST00000391413.2
|
KRTAP4-11
|
keratin associated protein 4-11 |
| chr19_-_42927251 | 1.96 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
| chr1_+_15736359 | 1.94 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
| chr11_+_94501497 | 1.93 |
ENST00000317829.8
ENST00000317837.9 ENST00000433060.2 |
AMOTL1
|
angiomotin like 1 |
| chr6_-_131291572 | 1.92 |
ENST00000529208.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr12_+_51632666 | 1.92 |
ENST00000604900.1
|
DAZAP2
|
DAZ associated protein 2 |
| chr13_+_78109884 | 1.91 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
| chr20_+_42295745 | 1.89 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr8_+_25316489 | 1.89 |
ENST00000330560.3
|
CDCA2
|
cell division cycle associated 2 |
| chr19_+_38810447 | 1.88 |
ENST00000263372.3
|
KCNK6
|
potassium channel, subfamily K, member 6 |
| chr9_+_128509663 | 1.87 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr20_+_62327996 | 1.86 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
| chr13_+_78109804 | 1.85 |
ENST00000535157.1
|
SCEL
|
sciellin |
| chr7_-_23510086 | 1.84 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
| chr11_-_71159380 | 1.83 |
ENST00000525346.1
ENST00000531364.1 ENST00000529990.1 ENST00000527316.1 ENST00000407721.2 |
DHCR7
|
7-dehydrocholesterol reductase |
| chr6_+_150070857 | 1.83 |
ENST00000544496.1
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase |
| chr4_-_80994471 | 1.83 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr4_-_80994619 | 1.82 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr2_-_27718052 | 1.81 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
| chr7_+_43622664 | 1.81 |
ENST00000319357.5
|
STK17A
|
serine/threonine kinase 17a |
| chr12_+_41086297 | 1.81 |
ENST00000551295.2
|
CNTN1
|
contactin 1 |
| chr7_+_77167376 | 1.80 |
ENST00000435495.2
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr1_+_55505184 | 1.79 |
ENST00000302118.5
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9 |
| chr3_-_128712906 | 1.77 |
ENST00000511438.1
|
KIAA1257
|
KIAA1257 |
| chr2_+_30454390 | 1.77 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr18_+_33877654 | 1.77 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr2_-_208031542 | 1.76 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr13_-_60738003 | 1.74 |
ENST00000400330.1
ENST00000400324.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr1_+_27320176 | 1.73 |
ENST00000522111.2
|
TRNP1
|
TMF1-regulated nuclear protein 1 |
| chr16_+_610407 | 1.73 |
ENST00000409413.3
|
C16orf11
|
chromosome 16 open reading frame 11 |
| chr19_+_10216899 | 1.72 |
ENST00000428358.1
ENST00000393796.4 ENST00000253107.7 ENST00000556468.1 ENST00000393793.1 |
PPAN-P2RY11
PPAN
|
PPAN-P2RY11 readthrough peter pan homolog (Drosophila) |
| chr13_+_98086445 | 1.70 |
ENST00000245304.4
|
RAP2A
|
RAP2A, member of RAS oncogene family |
| chr1_+_45265897 | 1.70 |
ENST00000372201.4
|
PLK3
|
polo-like kinase 3 |
| chr14_+_96343100 | 1.68 |
ENST00000503525.2
|
LINC00617
|
long intergenic non-protein coding RNA 617 |
| chr12_-_48152428 | 1.67 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr19_-_51014460 | 1.65 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr17_+_62223320 | 1.65 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
| chr12_-_52779433 | 1.64 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
| chr5_+_36152179 | 1.64 |
ENST00000508514.1
ENST00000513151.1 ENST00000546211.1 |
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
| chr7_+_73507409 | 1.64 |
ENST00000538333.3
|
LIMK1
|
LIM domain kinase 1 |
| chr19_-_40791211 | 1.63 |
ENST00000579047.1
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
| chr11_+_72929319 | 1.61 |
ENST00000393597.2
ENST00000311131.2 |
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
| chr1_+_41445413 | 1.61 |
ENST00000541520.1
|
CTPS1
|
CTP synthase 1 |
| chr1_-_93426998 | 1.60 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
| chr4_+_156680153 | 1.60 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr4_-_52904425 | 1.58 |
ENST00000535450.1
|
SGCB
|
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
| chr17_-_36981556 | 1.58 |
ENST00000536127.1
ENST00000225428.5 |
CWC25
|
CWC25 spliceosome-associated protein homolog (S. cerevisiae) |
| chr16_-_87903079 | 1.57 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr4_-_80994210 | 1.57 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr10_-_79397391 | 1.57 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr9_-_72287191 | 1.57 |
ENST00000265381.4
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1 |
| chr8_+_25316707 | 1.56 |
ENST00000380665.3
|
CDCA2
|
cell division cycle associated 2 |
| chr11_-_71159458 | 1.55 |
ENST00000355527.3
|
DHCR7
|
7-dehydrocholesterol reductase |
| chr2_+_11886710 | 1.55 |
ENST00000256720.2
ENST00000441684.1 ENST00000423495.1 |
LPIN1
|
lipin 1 |
| chr14_+_29236269 | 1.55 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr14_-_64194745 | 1.55 |
ENST00000247225.6
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1 |
| chr21_-_34960948 | 1.55 |
ENST00000453626.1
ENST00000303113.6 ENST00000432378.1 ENST00000303071.5 |
DONSON
|
downstream neighbor of SON |
| chr6_+_151561085 | 1.55 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr9_-_131644202 | 1.54 |
ENST00000320665.6
ENST00000436267.2 |
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
| chr7_+_76026832 | 1.54 |
ENST00000336517.4
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor) |
| chr2_+_23608064 | 1.53 |
ENST00000486442.1
|
KLHL29
|
kelch-like family member 29 |
| chr20_+_3776371 | 1.53 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
| chr17_+_39261584 | 1.51 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
| chr8_+_27182862 | 1.51 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chr6_-_42946888 | 1.50 |
ENST00000244546.4
|
PEX6
|
peroxisomal biogenesis factor 6 |
| chr7_+_155090271 | 1.49 |
ENST00000476756.1
|
INSIG1
|
insulin induced gene 1 |
| chr12_-_28122980 | 1.49 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr19_-_44031341 | 1.48 |
ENST00000600651.1
|
ETHE1
|
ethylmalonic encephalopathy 1 |
| chr15_-_74504597 | 1.47 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
| chr9_+_128509624 | 1.45 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr8_+_27183033 | 1.44 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
| chr3_-_185542761 | 1.44 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr19_-_44031375 | 1.43 |
ENST00000292147.2
|
ETHE1
|
ethylmalonic encephalopathy 1 |
| chr6_-_66417107 | 1.43 |
ENST00000370621.3
ENST00000370618.3 ENST00000503581.1 ENST00000393380.2 |
EYS
|
eyes shut homolog (Drosophila) |
| chr12_+_26274917 | 1.43 |
ENST00000538142.1
|
SSPN
|
sarcospan |
| chr15_+_40886199 | 1.43 |
ENST00000346991.5
ENST00000528975.1 ENST00000527044.1 |
CASC5
|
cancer susceptibility candidate 5 |
| chr12_-_53242770 | 1.42 |
ENST00000304620.4
ENST00000547110.1 |
KRT78
|
keratin 78 |
| chr11_+_72929402 | 1.42 |
ENST00000393596.2
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
| chr3_+_47324424 | 1.41 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
| chr21_+_30502806 | 1.41 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr9_-_131644306 | 1.40 |
ENST00000302586.3
|
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
| chrX_-_38080077 | 1.38 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr11_-_124311054 | 1.38 |
ENST00000328064.2
|
OR8B8
|
olfactory receptor, family 8, subfamily B, member 8 |
| chr3_-_12800751 | 1.38 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
| chr11_-_67981046 | 1.38 |
ENST00000402789.1
ENST00000402185.2 ENST00000458496.1 |
SUV420H1
|
suppressor of variegation 4-20 homolog 1 (Drosophila) |
| chr6_-_53213587 | 1.37 |
ENST00000542638.1
ENST00000370913.5 ENST00000541407.1 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
| chr1_-_159924006 | 1.37 |
ENST00000368092.3
ENST00000368093.3 |
SLAMF9
|
SLAM family member 9 |
| chr1_+_120254510 | 1.36 |
ENST00000369409.4
|
PHGDH
|
phosphoglycerate dehydrogenase |
| chr18_+_55102917 | 1.36 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
| chr3_-_71802760 | 1.36 |
ENST00000295612.3
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
| chr17_+_2699697 | 1.36 |
ENST00000254695.8
ENST00000366401.4 ENST00000542807.1 |
RAP1GAP2
|
RAP1 GTPase activating protein 2 |
| chr4_+_79472888 | 1.35 |
ENST00000512884.1
ENST00000512542.1 ENST00000503570.2 |
ANXA3
|
annexin A3 |
| chr12_-_129308487 | 1.35 |
ENST00000266771.5
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4 |
| chr16_-_2059797 | 1.35 |
ENST00000563630.1
|
ZNF598
|
zinc finger protein 598 |
| chr15_-_74504560 | 1.35 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr13_-_24007815 | 1.34 |
ENST00000382298.3
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
| chr4_-_80993717 | 1.34 |
ENST00000307333.7
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr12_+_22778291 | 1.34 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
| chr5_+_36152091 | 1.33 |
ENST00000274254.5
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
| chr19_+_18496957 | 1.32 |
ENST00000252809.3
|
GDF15
|
growth differentiation factor 15 |
| chr11_-_82708519 | 1.32 |
ENST00000534301.1
|
RAB30
|
RAB30, member RAS oncogene family |
| chr5_+_68463043 | 1.32 |
ENST00000508407.1
ENST00000505500.1 |
CCNB1
|
cyclin B1 |
| chrX_-_153775426 | 1.30 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr16_+_28889801 | 1.30 |
ENST00000395503.4
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
| chr13_+_28712614 | 1.30 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
| chr14_-_54955721 | 1.30 |
ENST00000554908.1
|
GMFB
|
glia maturation factor, beta |
| chr2_-_26205340 | 1.30 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
| chr2_+_204193129 | 1.30 |
ENST00000417864.1
|
ABI2
|
abl-interactor 2 |
| chr17_-_39769005 | 1.30 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr21_-_34960930 | 1.29 |
ENST00000437395.1
|
DONSON
|
downstream neighbor of SON |
| chr19_+_917287 | 1.29 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr20_-_10654639 | 1.29 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
| chr3_+_150126101 | 1.28 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
| chr1_+_90098606 | 1.28 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
| chr11_+_62649158 | 1.27 |
ENST00000539891.1
ENST00000536981.1 |
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
| chr10_-_101380121 | 1.27 |
ENST00000370495.4
|
SLC25A28
|
solute carrier family 25 (mitochondrial iron transporter), member 28 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MAFB
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 5.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.7 | 5.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 1.6 | 7.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 1.5 | 4.6 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 1.4 | 9.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.2 | 3.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.2 | 3.7 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 1.1 | 3.4 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.1 | 3.2 | GO:1903248 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.0 | 6.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.9 | 3.7 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 | 3.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.8 | 2.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) fast-twitch skeletal muscle fiber contraction(GO:0031443) relaxation of skeletal muscle(GO:0090076) |
| 0.8 | 4.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.8 | 2.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.8 | 2.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.8 | 2.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.8 | 4.5 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.7 | 4.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 | 3.0 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.7 | 2.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.7 | 2.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.7 | 3.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 | 2.1 | GO:0003169 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.7 | 2.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 | 3.4 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.6 | 2.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 4.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 | 2.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.6 | 4.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.6 | 1.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.6 | 2.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.6 | 3.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 15.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.5 | 1.6 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 3.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.5 | 2.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.5 | 1.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.5 | 3.2 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.5 | 4.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 | 0.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.5 | 0.5 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.5 | 5.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 2.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.5 | 3.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.5 | 2.0 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 1.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.5 | 3.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.5 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 2.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.5 | 1.5 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.5 | 2.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.5 | 1.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.5 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 1.4 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.5 | 1.4 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.4 | 1.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.4 | 2.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.4 | 1.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.4 | 1.3 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.4 | 4.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 | 1.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 | 1.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.4 | 3.0 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 | 1.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.4 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.4 | 2.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.4 | 0.8 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 | 1.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 1.6 | GO:0009644 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
| 0.4 | 3.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.4 | 0.4 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.4 | 1.6 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 1.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 | 1.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 | 1.2 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.4 | 0.4 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.4 | 4.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.4 | 3.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.4 | 1.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.4 | 1.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.4 | 1.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.4 | 2.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.4 | 1.8 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.4 | 1.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 | 1.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 | 3.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.3 | 2.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.3 | 1.0 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 0.3 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 1.0 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.3 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 1.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 1.0 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.3 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 3.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.3 | 1.5 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.3 | 2.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 4.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 0.3 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.3 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 0.8 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.3 | 6.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.3 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.3 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.3 | 0.8 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.3 | 4.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.3 | 0.5 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.3 | 1.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.3 | 0.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.3 | 1.3 | GO:0060356 | leucine import(GO:0060356) |
| 0.3 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.2 | 0.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.2 | 1.0 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.2 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.2 | 1.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.2 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 | 0.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.2 | 0.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 3.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.2 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.2 | 0.9 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.2 | 0.9 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.2 | 2.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.9 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.2 | 0.7 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 1.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 2.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 0.8 | GO:0048880 | sensory system development(GO:0048880) |
| 0.2 | 0.8 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 | 3.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.2 | 1.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 | 1.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 | 1.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.2 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.2 | 0.8 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.8 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.2 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 1.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 1.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.2 | 1.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 1.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 3.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.2 | 3.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 2.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.2 | 0.5 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 2.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.2 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 0.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 0.7 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 | 0.7 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 0.5 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 | 2.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 2.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 1.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.2 | 1.3 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 0.7 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 0.5 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 0.7 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.2 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 0.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.2 | 1.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.2 | 0.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.5 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.2 | 1.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 1.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.2 | 0.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 | 0.2 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.2 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.2 | 0.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 | 1.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 1.2 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 | 0.9 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 0.3 | GO:0006757 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) ADP metabolic process(GO:0046031) |
| 0.2 | 0.8 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.2 | 3.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 1.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.5 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.1 | 0.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.1 | 8.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 2.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.6 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 0.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 | 0.4 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 | 1.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.1 | 0.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 1.5 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 0.4 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 | 1.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 | 0.4 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 1.7 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.4 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 0.4 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 1.6 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
| 0.1 | 2.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 | 1.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 5.5 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.4 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.1 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 2.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 1.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 6.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 | 0.7 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 3.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.7 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 | 0.6 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 2.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 | 0.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.3 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 1.4 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.1 | 0.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 1.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 1.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.1 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 1.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 0.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 1.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 | 0.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 | 0.2 | GO:0002526 | acute inflammatory response(GO:0002526) |
| 0.1 | 0.9 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.4 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 0.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 1.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 1.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.6 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 0.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.1 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) cellular response to cGMP(GO:0071321) |
| 0.1 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.7 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 2.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.2 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.1 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 1.4 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 0.4 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 0.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.8 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 0.1 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 2.8 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.8 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 | 1.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 1.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) synaptic transmission, GABAergic(GO:0051932) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 2.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
| 0.1 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 0.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 3.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 1.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.3 | GO:1903336 | intralumenal vesicle formation(GO:0070676) negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 0.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 0.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 0.3 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.1 | 0.3 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 0.3 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.1 | 0.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 0.2 | GO:0035568 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.1 | 3.0 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 1.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 1.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 | 0.3 | GO:0010256 | endomembrane system organization(GO:0010256) |
| 0.1 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 | 0.6 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.1 | 0.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.1 | 0.3 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 0.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.1 | 0.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.1 | 0.2 | GO:0050650 | chondroitin sulfate biosynthetic process(GO:0030206) chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 1.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 | 1.8 | GO:0006954 | inflammatory response(GO:0006954) |
| 0.1 | 0.4 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 | 0.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.1 | 1.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 0.8 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.1 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.2 | GO:0002188 | formation of cytoplasmic translation initiation complex(GO:0001732) translation reinitiation(GO:0002188) |
| 0.1 | 0.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 | 0.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.1 | 0.1 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 | 0.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.2 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.1 | 0.3 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 6.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 1.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 0.3 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
| 0.1 | 0.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.1 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 | 1.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.1 | GO:1901069 | hypoxanthine salvage(GO:0043103) guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.5 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.1 | 1.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 1.7 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 0.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 1.0 | GO:1901897 |